Global Biopharmaceutical CDMO Competitive Landscape Professional Research Report 2025
Description
Global Biopharmaceutical CDMO Competitive Landscape Professional Research Report 2025
Research Summary
A biopharmaceutical Contract Development and Manufacturing Organization (CDMO) is a company that provides contract services for the development, manufacturing, and testing of biopharmaceutical products on behalf of pharmaceutical and biotechnology companies. These CDMOs offer a comprehensive range of services, including process development, analytical testing, formulation development, cell line development, and manufacturing of biologics such as monoclonal antibodies, recombinant proteins, vaccines, gene therapies, and cell therapies. By outsourcing these activities to a CDMO, companies can leverage the CDMO＇s expertise, facilities, and resources to accelerate product development, reduce costs, and focus on core competencies while ensuring quality, safety, and compliance with regulatory standards.
According to DIResearch's in-depth investigation and research, the global Biopharmaceutical CDMO market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Biopharmaceutical CDMO include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific, AGC Biologics, Rentschler Biopharma, KBI Biopharma, Siegfried, Aenova Group, GenScript, ProBioGen, Northway Biotech, 3P Biopharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biopharmaceutical CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biopharmaceutical CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biopharmaceutical CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biopharmaceutical CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Biopharmaceutical CDMO Include:
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Biopharmaceutical CDMO Product Segment Include:
Cell and Gene Therapies
Antibodies
Vaccines
Others
Biopharmaceutical CDMO Product Application Include:
SMBs
Large Companies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Biopharmaceutical CDMO Industry PESTEL Analysis
Chapter 3: Global Biopharmaceutical CDMO Industry Porter’s Five Forces Analysis
Chapter 4: Global Biopharmaceutical CDMO Major Regional Market Size and Forecast Analysis
Chapter 5: Global Biopharmaceutical CDMO Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Biopharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Biopharmaceutical CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Biopharmaceutical CDMO Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Biopharmaceutical CDMO Product by Type
- 1.2.1 Cell and Gene Therapies
- 1.2.2 Antibodies
- 1.2.3 Vaccines
- 1.2.4 Others
- 1.3 Biopharmaceutical CDMO Product by Application
- 1.3.1 SMBs
- 1.3.2 Large Companies
- 1.4 Global Biopharmaceutical CDMO Market Size Analysis (2020-2032)
- 1.5 Biopharmaceutical CDMO Market Development Status and Trends
- 1.5.1 Biopharmaceutical CDMO Industry Development Status Analysis
- 1.5.2 Biopharmaceutical CDMO Industry Development Trends Analysis
- 2 Biopharmaceutical CDMO Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Biopharmaceutical CDMO Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Biopharmaceutical CDMO Market Analysis by Regions
- 4.1 Biopharmaceutical CDMO Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Biopharmaceutical CDMO Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Biopharmaceutical CDMO Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Biopharmaceutical CDMO Revenue Forecast by Region (2026-2032)
- 5 Global Biopharmaceutical CDMO Market Size by Type and Application
- 5.1 Global Biopharmaceutical CDMO Market Size by Type (2020-2032)
- 5.2 Global Biopharmaceutical CDMO Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Biopharmaceutical CDMO Market Size by Type
- 6.4 North America Biopharmaceutical CDMO Market Size by Application
- 6.5 North America Biopharmaceutical CDMO Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Biopharmaceutical CDMO Market Size by Type
- 7.4 Europe Biopharmaceutical CDMO Market Size by Application
- 7.5 Europe Biopharmaceutical CDMO Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Biopharmaceutical CDMO Market Size by Type
- 8.4 China Biopharmaceutical CDMO Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Biopharmaceutical CDMO Market Size by Type
- 9.4 APAC (excl. China) Biopharmaceutical CDMO Market Size by Application
- 9.5 APAC (excl. China) Biopharmaceutical CDMO Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Biopharmaceutical CDMO Market Size by Type
- 10.4 Latin America Biopharmaceutical CDMO Market Size by Application
- 10.5 Latin America Biopharmaceutical CDMO Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Biopharmaceutical CDMO Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Biopharmaceutical CDMO Market Size by Type
- 11.4 Middle East & Africa Biopharmaceutical CDMO Market Size by Application
- 11.5 Middle East & Africa Biopharmaceutical CDMO Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Biopharmaceutical CDMO Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Biopharmaceutical CDMO Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Biopharmaceutical CDMO Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Lonza
- 13.1.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Lonza Biopharmaceutical CDMO Product Portfolio
- 13.1.3 Lonza Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Catalent
- 13.2.1 Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Catalent Biopharmaceutical CDMO Product Portfolio
- 13.2.3 Catalent Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Samsung Biologics
- 13.3.1 Samsung Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Samsung Biologics Biopharmaceutical CDMO Product Portfolio
- 13.3.3 Samsung Biologics Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 FUJIFILM Diosynth Biotechnologies
- 13.4.1 FUJIFILM Diosynth Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Product Portfolio
- 13.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Boehringer Ingelheim
- 13.5.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Boehringer Ingelheim Biopharmaceutical CDMO Product Portfolio
- 13.5.3 Boehringer Ingelheim Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 WuXi AppTech
- 13.6.1 WuXi AppTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 WuXi AppTech Biopharmaceutical CDMO Product Portfolio
- 13.6.3 WuXi AppTech Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Recipharm
- 13.7.1 Recipharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Recipharm Biopharmaceutical CDMO Product Portfolio
- 13.7.3 Recipharm Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Thermo Fisher Scientific
- 13.8.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Thermo Fisher Scientific Biopharmaceutical CDMO Product Portfolio
- 13.8.3 Thermo Fisher Scientific Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 AGC Biologics
- 13.9.1 AGC Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 AGC Biologics Biopharmaceutical CDMO Product Portfolio
- 13.9.3 AGC Biologics Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Rentschler Biopharma
- 13.10.1 Rentschler Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Rentschler Biopharma Biopharmaceutical CDMO Product Portfolio
- 13.10.3 Rentschler Biopharma Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 KBI Biopharma
- 13.11.1 KBI Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 KBI Biopharma Biopharmaceutical CDMO Product Portfolio
- 13.11.3 KBI Biopharma Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Siegfried
- 13.12.1 Siegfried Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Siegfried Biopharmaceutical CDMO Product Portfolio
- 13.12.3 Siegfried Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Aenova Group
- 13.13.1 Aenova Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Aenova Group Biopharmaceutical CDMO Product Portfolio
- 13.13.3 Aenova Group Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 GenScript
- 13.14.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 GenScript Biopharmaceutical CDMO Product Portfolio
- 13.14.3 GenScript Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 ProBioGen
- 13.15.1 ProBioGen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 ProBioGen Biopharmaceutical CDMO Product Portfolio
- 13.15.3 ProBioGen Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Northway Biotech
- 13.16.1 Northway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Northway Biotech Biopharmaceutical CDMO Product Portfolio
- 13.16.3 Northway Biotech Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 3P Biopharmaceuticals
- 13.17.1 3P Biopharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 3P Biopharmaceuticals Biopharmaceutical CDMO Product Portfolio
- 13.17.3 3P Biopharmaceuticals Biopharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Biopharmaceutical CDMO Industry Chain Analysis
- 14.2 Biopharmaceutical CDMO Industry Raw Material and Suppliers Analysis
- 14.2.1 Biopharmaceutical CDMO Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Biopharmaceutical CDMO Typical Downstream Customers
- 14.4 Biopharmaceutical CDMO Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
